Cordycepin ameliorates autoimmunity by promoting STING degradation via autophagy pathway
British Journal of Pharmacology · 2025-04 · 182 (7) · 1546-1560
DOI: 10.1111/bph.17425 ↗At a glance
Journal article in British Journal of Pharmacology, published online on 2024-12-15. Written by Daidi Yang and 5 co-authors. Institution: Department of Ophthalmology, The First People's Hospital of Wuhu, Wuhu, China. Major MEDLINE topics: Deoxyadenosines, Membrane Proteins, Autophagy, Autoimmunity. Cited 13 times so far (Crossref); 42 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Abstract (original language)
Background and Purpose Stimulator of interferon response cGAMP interactor 1 (STING), a central hub protein of cyclic GMP‐AMP synthase (cGAS)–STING signalling pathway, has a crucial role in regulating type I interferons (IFNs) production and response. Recent studies indicate that excessive activation of STING is strongly associated with autoimmune diseases, including systemic lupus erythematosus (SLE). Searching immunomodulators that negatively regulate STING might greatly contribute to the suppression of autoimmunity. Experimental Approach The peripheral blood mononuclear cells (PBMCs) of SLE patients, Hela cells, L929 cells and bone marrow‐derived macrophages (BMDMs) from mice were used as in vitro models. While, Trex1 KO mouse autoimmune disease model was used as in vivo model. After treatment with cordycepin, a nucleoside from Cordyceps mushrooms, type I IFNs production and response were determined by western blotting, real‐time polymerase chain reaction (PCR), dual‐luciferase assay, enzyme‐linked immunosorbent assay (ELISA), haematoxylin–eosin staining and RNA‐seq. Key Results Cordycepin inhibited type I IFNs production and response in human and murine systems following cGAS–STING signalling activation. Importantly, cordycepin markedly attenuates the autoinflammatory and autoimmune responses in Trex1 KO BMDMs and Trex1 KO mice. Furthermore, cordycepin effectively suppressed the production of type I IFNs and interferon‐stimulated genes ( ISG s) in the PBMCs of SLE patients. Mechanistically, cordycepin promoted STING degradation via autophagy pathway upon DNA stimulation. Conclusion and Implications This study shows that cordycepin promotes STING autophagic degradation to alleviate autoimmunity upon DNA stimulation. Cordycepin might be a potential therapeutic candidate for alleviating aberrant type I IFNs in autoimmune and autoinflammatory diseases.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Ophthalmology, The First People's Hospital of Wuhu, Wuhu, China.
- School of Pharmacy, Jiangsu Food and Pharmaceutical Science College, Huaian, China.
- School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.
- Guangdong Provincial Key Laboratory of Speed Capability Research, School of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
- Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of Biomedical Science, City University of Hong Kong, Kowloon, Hong Kong.
ORCID profiles: Mingyu Pan
Funding
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
Cite
APA
Yang, D., Peng, N., Zhang, H., Qiu, Z., Xu, L., & Pan, M. (2025). Cordycepin ameliorates autoimmunity by promoting STING degradation via autophagy pathway. British Journal of Pharmacology, 182(7), 1546-1560. https://doi.org/10.1111/bph.17425
Vancouver
Yang D, Peng N, Zhang H, Qiu Z, Xu L, Pan M. Cordycepin ameliorates autoimmunity by promoting STING degradation via autophagy pathway. British Journal of Pharmacology. 2025;182(7):1546-1560. doi:10.1111/bph.17425
BibTeX
@article{Yang2025,
author = {Yang, Daidi and Peng, Niannian and Zhang, Hongqian and Qiu, Zuocheng and Xu, Lingxiao and Pan, Mingyu},
title = {Cordycepin ameliorates autoimmunity by promoting STING degradation via autophagy pathway},
journal = {British Journal of Pharmacology},
year = {2025},
volume = {182},
number = {7},
pages = {1546--1560},
doi = {10.1111/bph.17425}
}
EUVIMED